Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 23, Number 14, 2017

Articles

Free Content Editorial: (Pharmaco)Metabolomics in Drug Discovery and Individualisation of Treatment
pp. 2027-2027(1)
Authors: Katsila, Theodora; P. Patrinos, George

Favourites:
ADD

Pharmacogenetics and Metabolism from Science to Implementation in Clinical Practice: The Example of Dihydropyrimidine Dehydrogenase
pp. 2028-2034(7)
Authors: Del Re, Marzia; Restante, Giuliana; Di Paolo, Antonello; Crucitta, Stefania; Rofi, Eleonora; Danesi, Romano

Favourites:
ADD

In vivo Phenotyping Methods: Cytochrome P450 Probes with Emphasis on the Cocktail Approach
pp. 2035-2049(15)
Authors: Alberto Keller, Guillermo; Laura Ferreirós Gago, María; Alejandro Diez, Roberto; Di Girolamo, Guillermo

Favourites:
ADD

Metabolomics in the Diagnosis and Pharmacotherapy of Lung Diseases
pp. 2050-2059(10)
Authors: Devillier, Philippe; Salvator, Helene; Naline, Emmanuel; Couderc, Louis-Jean; Grassin-Delyle, Stanislas

Favourites:
ADD

CYP4Z1 – A Human Cytochrome P450 Enzyme that Might Hold the Key to Curing Breast Cancer
pp. 2060-2064(5)
Authors: Yang, Xu; Hutter, Michael; Wen Bin Goh, Wilson; Bureik, Matthias

Favourites:
ADD

Role of Proinflammatory Cytokines in Dopaminergic System Disturbances, Implications for Anhedonic Features of MDD
pp. 2065-2072(8)
Authors: Pan, Zihang; D. Rosenblat, Joshua; Swardfager, Walter; S. McIntyre, Roger

Favourites:
ADD

Open Access Selective Inhibition of Phosphodiesterases 4A, B, C and D Isoforms in Chronic Respiratory Diseases: Current and Future Evidences
pp. 2073-2083(11)
Authors: Contreras, Sonia; Milara, Javier; Morcillo, Esteban; Cortijo, Julio

Favourites:
ADD

Biofilm-mediated Antibiotic-resistant Oral Bacterial Infections: Mechanism and Combat Strategies
pp. 2084-2095(12)
Authors: Kanwar, Indulata; K. Sah, Abhishek; K. Suresh, Preeti

Favourites:
ADD

Cyclodextrins as Complexation Agents to Improve the Anti-inflammatory Drugs Profile: a Systematic Review and Meta-Analysis
pp. 2096-2107(12)
Authors: L. Santos, Priscila; G. Brito, Renan; S.S. Quintans, Jullyana; A.S. Araujo, Adriano; R.A. Menezes, Irwin; K. Brogden, Nicole; J. Quintans-Junior, Lucindo

Favourites:
ADD

Introduction for Design of Nanoparticle Based Drug Delivery Systems
pp. 2108-2112(5)
Authors: Yan Chan Edgar, Jun; Wang, Hui

Favourites:
ADD

Open Access Anti-EGFRvIII Chimeric Antigen Receptor-Modified T Cells for Adoptive Cell Therapy of Glioblastoma
pp. 2113-2116(4)
Authors: Ren, Pei-pei; Li, Ming; Li, Tian-fang; Han, Shuang-yin

Favourites:
ADD

Discovery and Optimization of NAD+-Dependent DNA Ligase Inhibitors as Novel Antibacterial Compounds
pp. 2117-2130(14)
Authors: Bi, Fangchao; Ma, Ruixin; Ma, Shutao

Favourites:
ADD

Open Access Macrocyclic Antimicrobial Peptides Engineered from ω-Conotoxin
pp. 2131-2138(8)
Authors: Hemu, Xinya; P. Tam, James

Favourites:
ADD

Dendritic Cells Modulate Iron Homeostasis and Inflammatory Abilities Following Quercetin Exposure
pp. 2139-2146(8)
Authors: Galleggiante, Vanessa; De Santis, Stefania; Cavalcanti, Elisabetta; Scarano, Aurelia; De Benedictis, Maria; Serino, Grazia; Lucia Caruso, Maria; Mastronardi, Mauro; Pinto, Aldo; Campiglia, Pietro; Kunde, Dale; Santino, Angelo; Chieppa, Marcello

Favourites:
ADD

In Vitro Screening of an FDA-Approved Library Against ESKAPE Pathogens
pp. 2147-2157(11)
Authors: Younis, Waleed; AbdelKhalek, Ahmed; S. Mayhoub, Abdelrahman; N. Seleem, Mohamed

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content